Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lars Brüll"'
Autor:
Leon Coulier, Mariska L. Reedijk, Albert D. M. E. Osterhaus, Theo M. Luider, Henk Gerritsen, Lars Brüll, Jeroen J. A. van Kampen, Rob A. Gruters
Publikováno v:
Journal of Chromatography B. Analytical Technologies in the Biomedical and Life Sciences, 879(26), 2772-2782. Elsevier
Nucleoside reverse transcriptase inhibitors (NRTIs) are a key class of drugs for the treatment of HIV infection. NRTIs are intracellularly phosphorylated to their active triphosphate metabolites and compete with endogenous deoxynucleotides (dNTP) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af2a0b5d682f98f5a8fb3e19ecdf0acc
https://pure.eur.nl/en/publications/26d897de-4f62-4fc8-82ba-3e8b41836568
https://pure.eur.nl/en/publications/26d897de-4f62-4fc8-82ba-3e8b41836568
Autor:
Ronald de Groot, Henk Gerritsen, Theo M. Luider, Lars Brüll, Leon Coulier, William D van Dongen, Richard C. Bas, Jeroen J. A. van Kampen
Publikováno v:
Proteomics Clinical Applications, 2(10-11), 1557-1562. Wiley-VCH
Proteomics-Clinical Applications, 10-11, 2, 1557-1562
Proteomics-Clinical Applications, 10-11, 2, 1557-1562
Nucleoside reverse transcriptase inhibitors (NRTIs) are activated intracellularly to their triphosphate (TP) form, which compete with endogenous deoxynucleotide-triphosphates (dNTP) as substrate for HIV reverse transcriptase. The activity of NRTIs is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb64ec442feee6f5024beb375e604b6b
https://pure.eur.nl/en/publications/8e7af930-ef70-4270-8a91-25d8d9ed2134
https://pure.eur.nl/en/publications/8e7af930-ef70-4270-8a91-25d8d9ed2134